Cargando…

A novel preclinical murine model of immune-mediated metastatic dormancy

The mechanisms underlying cancer dormancy are poorly understood. We have developed a preclinical murine model in which immunosurveillance restrains spontaneous metastases in permanent dormancy. The model faithfully recapitulates human metastatic dormancy and may be useful to decipher the immune mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero, Irene, Garrido, Federico, Garcia-Lora, Angel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108459/ https://www.ncbi.nlm.nih.gov/pubmed/25083338 http://dx.doi.org/10.4161/onci.29258

Ejemplares similares

Itraconazole perturbs colorectal cancer dormancy through SUFU-mediated WNT inhibition
por: Popova, Semiramis A., et al.
Publicado: (2018)

Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies: Lessons from a preclinical model
por: Garrido, Greta, et al.
Publicado: (2013)

Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells
por: Liang, Hua, et al.
Publicado: (2013)

miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells
por: Gaziel-Sovran, Avital, et al.
Publicado: (2012)

Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020)

Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models
por: Bouchlaka, Myriam N, et al.
Publicado: (2013)

A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2013)

A(2A) blockade enhances anti-metastatic immune responses
por: Beavis, Paul A, et al.
Publicado: (2013)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
por: Cooper, Zachary A, et al.
Publicado: (2014)

Glycan-mediated modification of the immune response
por: Madsen, Caroline B., et al.
Publicado: (2013)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen
por: Rosental, Benyamin, et al.
Publicado: (2012)

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
por: Baldin, Pamela, et al.
Publicado: (2020)

IRF-1 is critical for IFNγ mediated immune surveillance
por: Ksienzyk, Antje, et al.
Publicado: (2012)

A novel role for granzymes in anti-tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2012)

Regulation of DC development and DC-mediated T-cell immunity via CISH
por: Miah, Mohammad Alam, et al.
Publicado: (2013)

Immune-mediated tumor evolution: Nanog links the emergence of a stem like cancer cell state and immune evasion
por: Mao, Chih-Ping, et al.
Publicado: (2014)

Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
por: Jinushi, Masahisa
Publicado: (2012)

Stress-induced metastatic niches in breast cancer
por: Oskarsson, Thordur
Publicado: (2020)

Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells
por: Bonaccorsi, Irene, et al.
Publicado: (2014)

Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond
por: Urbanska, Katarzyna, et al.
Publicado: (2012)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

A “vicious cycle” of NK-cell immune evasion in acute myeloid leukemia mediated by RANKL?
por: Schmiedel, Benjamin Joachim, et al.
Publicado: (2013)

Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors
por: Malchow, Sven, et al.
Publicado: (2013)

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche
por: Sceneay, Jaclyn, et al.
Publicado: (2013)

Tumor stiffness extends its grip on the metastatic microenvironment
por: Reid, Steven E., et al.
Publicado: (2017)

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
por: Rossig, Claudia
Publicado: (2012)

Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
por: Jacquelot, Nicolas, et al.
Publicado: (2021)

Ethanolamine: A novel anti-aging agent
por: Rockenfeller, Patrick, et al.
Publicado: (2015)

PSPC1 potentiates TGF-β-dependent metastatic dissemination
por: Yeh, Hsi-Wen, et al.
Publicado: (2018)

Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?
por: Calabrò, Luana, et al.
Publicado: (2014)

IgG4 antibodies and cancer-associated inflammation: Insights into a novel mechanism of immune escape
por: Karagiannis, Panagiotis, et al.
Publicado: (2013)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients
por: Kakavand, Hojabr, et al.
Publicado: (2013)

Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015)

Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environment
por: Ménétrier-Caux, Christine, et al.
Publicado: (2012)

KLRG1(+) natural killer cells protect against pulmonary metastatic disease by immunosurveillance
por: Renner, Philipp, et al.
Publicado: (2014)

A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4(+) T-cell maturation
por: Brisson, Lydie, et al.
Publicado: (2015)

WNT-mediated gene gating: a novel principle connecting oncogenic super-enhancers with the nuclear pore to drive pathological expression of MYC
por: Göndör, Anita
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kltvum6eo5gu00vib5s71fbdc2